New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

When done safely and securely, automated inbound engagement can provide significant benefits for pharmaceutical companies.

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

M&A in biotech and pharma is expected to surge in late 2024 as regulatory uncertainties ease. Discover trends, key players, and areas of high interest.

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...